Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Characterization of Patients With Geographic Atrophy (GA) in the US
Authors not listed
Boehringer Ingelheim · 2023
Abstract
To quantify and describe patients with a Geographic Atrophy (GA) diagnosis in at least one eye, and the progression to neovascular Age-Related Macular Degeneration (including how many receive Anti-VEGF), or to GA (in the fellow eye only).
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-09 MST
Cite this
APA
Anonymous. (2023). Characterization of Patients With Geographic Atrophy (GA) in the US. <em>Boehringer Ingelheim</em>. https://clinicaltrials.gov/study/NCT05891275
Vancouver
Anonymous. Characterization of Patients With Geographic Atrophy (GA) in the US. Boehringer Ingelheim. 2023.
BibTeX
@misc{anon2023Charac,
title = {Characterization of Patients With Geographic Atrophy (GA) in the US},
author = {Anonymous},
journal = {Boehringer Ingelheim},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Ophthalmology 2018
Open access · OA
Progression of Geographic Atrophy in Age-related Macular Degeneration
Institut de la Macula y la Retina 2009
Open access · US-GOV
Characterization of Geographic Atrophy Progression in Patients With Age-related Macular Degeneration
American Journal of Ophthalmology 2002
Citation only
Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration.
Pfizer 2010
Open access · US-GOV
A PHASE 1, DOUBLE-MASKED, PLACEBO-CONTROLLED STUDY EVALUATING THE SAFETY, TOLERABILITY, IMMUNOGENICITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF MULTIPLE ESCALATING DOSAGES OF RN6G (PF-04382923) IN SUBJECTS WITH ADVANCED DRY, AGE-RELATED MACULAR DEGENERATION (AMD) INCLUDING GEOGRAPHIC ATROPHY
New England Journal of Medicine 2008
Open access · OA
Toll-like Receptor 3 and Geographic Atrophy in Age-Related Macular Degeneration
Ohr Pharmaceutical Inc. 2016
Open access · US-GOV